Urinary tract infection caused by Staphylococcus saprophyticus.
about
Colonization of the female genital tract with Staphylococcus saprophyticusStaphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environmentsRecognition of Staphylococcus saprophyticus in urine cultures by screening colonies for production of phosphataseSpecies identification and susceptibility to 17 antibiotics of coagulase-negative staphylococci isolated from clinical specimens.Staphylococcus saprophyticus Recovered from Humans, Food, and Recreational Waters in Rio de Janeiro, Brazil.Staphylococcus colonization of the skin and antimicrobial peptides.Development of a rapid PCR assay specific for Staphylococcus saprophyticus and application to direct detection from urine samplesStaphylococcus saprophyticus as a urinary pathogen: a six year prospective survey.Characterization of mechanisms of resistance to beta-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticusSingle-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infectionsStaphylococcus saprophyticus beta-lactamase production and disk diffusion susceptibility testing for three beta-lactam antimicrobial agents.Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli.Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal floraComparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.Antimicrobial susceptibility of Staphylococcus saprophyticus and urethral staphylococci.Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.Antimicrobial susceptibilities of coagulase-negative staphylococci isolated from urinary infectionsSusceptibility of clinical isolates of Staphylococcus saprophyticus to fifteen commonly used antimicrobial agents.Loracarbef versus cefaclor in the treatment of urinary tract infections in women.Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in womenAntibiograms from community-acquired uropathogens in Gulu, northern Uganda--a cross-sectional study.Slime production by Staphylococcus saprophyticus.Problems with rapid agglutination methods for identification of Staphylococcus aureus when Staphylococcus saprophyticus is being testedIdentification of coagulase-negative staphylococci with the API STAPH-IDENT systemFive-hour novobiocin test for differentiation of coagulase-negative staphylococciIdentification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy.Characterization of Micrococcaceae strains isolated from the human urogenital tract by the conventional scheme and a micromethod.Clinical significance of coagulase-negative staphylococci.Staphylococcus saprophyticus as a cause of urinary tract infections.Acute pyelonephritis caused by Staphylococcus xylosus.Use of Mueller-Hinton agar to determine novobiocin susceptibility of coagulase-negative staphylococci.Characterization of coagulase-negative staphylococci from urinary tract specimensComparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci.Use of a novobiocin-containing medium for isolation of Staphylococcus saprophyticus from urineSpecies identification and antibiotic susceptibilities of coagulase-negative staphylococci isolated from clinical specimens.Clinical comparison of the AutoMicrobic system gram-positive identification card, API Staph-Ident, and conventional methods in the identification of coagulase-negative Staphylococcus spp.New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens.Rapid determination of novobiocin resistance of coagulase-negative staphylococci with the MS-2 system.
P2860
Q24653461-E1F86C87-7DAF-4DE0-BB9E-1ADCF7795CC9Q28087340-B5F96367-1F01-4CE7-A340-7189AB50BF27Q28360258-08722A88-11CA-43BB-9E93-FDA1B48608AFQ30451618-33409086-BFBA-411C-9517-B341FC3B6938Q33775413-330912F9-D437-4D2D-A057-88906009BB28Q33840268-5439A270-CF36-4C62-B9C0-2C551A5DC725Q33969591-71029844-844C-47CD-B8B0-712BA7F40D08Q34489804-A99CFEC7-702E-4D3E-8C19-778DFFC7AEB9Q35273500-90F50D59-4D8A-4739-9A45-EEB25CAAFD5DQ35341653-E17C1133-927B-4C28-9DDB-6352B1BC5C25Q35569392-9CA0CDCC-6EF6-47D0-88E3-F49F48F089ABQ35640444-9177375B-CB42-4051-BA82-9E327C621C3FQ35641911-226879DF-E5CF-406D-955D-84FD4CCFA7B9Q35648499-35C2FDCA-13F1-4E62-ADE6-A46B16986817Q35669330-CE8844EB-0A6C-4F86-BF67-BB8546C28B8EQ35669909-267BA83D-5451-4EA4-881A-9F5E7C7F071EQ35716297-448BA625-B44A-4E16-B7D4-9F96F806F010Q35718658-2939C0B7-1785-4ED9-BC45-6F8D3A7B389DQ35742767-01D805E8-8FD9-4E13-BC34-6DEBC14C4867Q35761334-DBCA098C-464F-46FB-8604-EFF8A89111FBQ36753423-F2A3DC38-D49C-4006-A407-A6C9A03C8D77Q36755115-295D6494-75D2-4435-B37D-9BB1C8F11C30Q36814960-39CC296D-3CB0-44BF-8190-2ECFFF7F5FA7Q36960449-1B6C7BE9-5168-44B2-BFE1-461E4746BBA2Q37151851-4E4F44A7-FB56-40A3-A2E5-400C32613DF5Q37255061-7A2E251A-16DA-4FAA-B465-0EB81FFD0BE7Q37261035-16D603CC-2F7B-49D8-B2C2-9F13C1F9A205Q37265050-317F6C48-20FF-4DC5-B90C-B4F594D19170Q37278377-EFCE9B3D-269B-48B4-8FC1-40ED24E7D927Q37296031-4FBFA2BC-D2E7-49E5-98C7-A5B254EDD350Q37297298-67B5BFD9-E04D-4A3E-91EC-C834A8AAFAC7Q37298405-05BB08D2-8979-47ED-916E-F894DEDB35C6Q37301955-534CBA2B-D668-4CC7-AC10-682E6D63C8C9Q37303569-B4B48736-9133-4B37-BFEE-1A19DD10F5F0Q37304857-9736A743-2EA1-4986-919A-8AD37D5E8E3FQ37308672-847818A0-B4D2-4ECB-AA92-4F1E54F9F107Q37310646-4F97C3C4-3B4A-4263-9B02-5BC13F87EC52Q37310716-713FEB77-F494-4137-85BC-6423E654C8EFQ40201413-48C332D9-4EC1-4DB1-8952-B8143D35F69AQ40226393-F9229471-7CFB-43F1-9108-54522AFF1CFE
P2860
Urinary tract infection caused by Staphylococcus saprophyticus.
description
1980 nî lūn-bûn
@nan
1980 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Urinary tract infection caused by Staphylococcus saprophyticus.
@ast
Urinary tract infection caused by Staphylococcus saprophyticus.
@en
Urinary tract infection caused by Staphylococcus saprophyticus.
@nl
type
label
Urinary tract infection caused by Staphylococcus saprophyticus.
@ast
Urinary tract infection caused by Staphylococcus saprophyticus.
@en
Urinary tract infection caused by Staphylococcus saprophyticus.
@nl
prefLabel
Urinary tract infection caused by Staphylococcus saprophyticus.
@ast
Urinary tract infection caused by Staphylococcus saprophyticus.
@en
Urinary tract infection caused by Staphylococcus saprophyticus.
@nl
P2093
P356
P1476
Urinary tract infection caused by Staphylococcus saprophyticus.
@en
P2093
P304
P356
10.1093/INFDIS/142.4.510
P407
P577
1980-10-01T00:00:00Z